Drug Profile
CGX 1160
Alternative Names: Contulakin-GLatest Information Update: 29 Apr 2008
Price :
$50
*
At a glance
- Originator Cognetix
- Class Analgesics; Antiepileptic drugs
- Mechanism of Action Neurotensin type 1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Neuropathic pain